Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
M&A activity
confidence 95%
filed 2026-09-22
Item 8.01
Beam Global announced entry into a non-binding letter of intent to acquire a European drone technology company, representing a material strategic expansion into the drone industry. The press release emphasizes this as "one of the most significant strategic advances in our company's history" and describes plans to manufacture drones in U.S. facilities, integrate proprietary technology, and leverage existing customer relationships with military and government entities. Although the transaction remains subject to due diligence and execution of definitive agreements, the announcement of the LOI constitutes a material M&A activity disclosure under Item 8.01.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-09-22
Item 8.01
The Board of Directors declared a regular quarterly cash dividend of $0.17 per common share, payable November 2, 2026. This is a straightforward dividend distribution event. While routine for established dividend-paying companies, dividend declarations are material to shareholders and investors assessing capital allocation and shareholder returns.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-22
Item 5.02
Matthew J. Cushing was appointed as a director of ECB Bancorp, Inc. and its subsidiary Everett Co-operative Bank on September 16, 2026, with a term expiring at the 2027 annual meeting. He was also appointed to the Audit Committee. This is a clear executive appointment disclosure under Item 5.02, and director appointments are material to investors as they affect board composition and governance.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-22
Item 2.02
The filing discloses Aytu BioPharma's fiscal 2026 fourth quarter and full-year operational and financial results via a press release (Exhibit 99.1). The disclosure includes detailed revenue figures by product portfolio, gross profit, operating expenses, net loss, Adjusted EBITDA, and cash position—all standard components of an earnings release. The company explicitly scheduled a conference call for September 22, 2026, to discuss these results, which is typical for earnings announcements.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-09-22
Item 8.01
The filing discloses a declaration of a cash dividend of $0.20 per share payable on October 16, 2026, to shareholders of record as of October 2, 2026. This is a straightforward dividend distribution announcement by the Board of Directors, which is a material event affecting shareholder returns and capital allocation policy.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-09-22
Item 1.01
This disclosure describes entry into a material definitive agreement for a business combination involving Plutonian Acquisition Corp. II (a SPAC) merging with NT1 Pty Ltd, with NT1 shareholders receiving 50,000,000 shares valued at $500,000,000. The agreement includes customary closing conditions, covenants, representations and warranties, and termination provisions with a $500,000 breakup fee. This is a classic M&A transaction combining a SPAC with an operating company, clearly falling under Item 1.01 and the ma_activity event type.
View raw filing on EDGAR →
8-K
Operational Other
confidence 65%
filed 2026-09-22
Item 1.01
CTT Pharmaceutical entered into a material definitive agreement. The specific nature of the agreement—whether a supply contract, licensing deal, partnership, or other operational arrangement—is not detailed in the Item 1.01 disclosure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-22
Item 8.01
Karen Larson was appointed as an Independent Board Member of CTT Pharmaceutical. The appointment is material as board composition changes affect investor assessment of corporate governance and oversight.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-09-22
Item 5.02
Tara Van Houweling, the Reporting Director and Principal Accounting Officer, notified the company of her intent to leave effective October 9, 2026, after 23 years of service. While the filing also mentions Kent Townsend assuming the Principal Accounting Officer role, the principal disclosed action is the departure of a named officer responsible for accounting oversight. The departure of a Principal Accounting Officer is material to investors assessing the registrant's financial reporting controls and governance.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-22
The filing discloses completion of U.S. GoldMining's 2026 exploration drill program at its Whistler Gold-Copper Project in Alaska, with 7,493 meters drilled across 17 holes targeting high-priority porphyry centers. This is an operational milestone for an exploration-stage company advancing its primary asset, supported by a March 2026 PEA showing US$2.04 billion after-tax NPV and 33% IRR. While the disclosure is furnished under Item 7.01 (Regulation FD) rather than a dedicated 8-K item, the completion of a record drilling program and anticipated assay results represent material operational progress for a development-stage mining company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-22
The filing discloses the appointment of Jaime K. Pickett as a director of PetVivo Holdings, Inc., effective September 22, 2026, to fill a vacancy created by Diane Levitan's resignation. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new director with extensive veterinary healthcare and executive leadership experience. The Board explicitly determined that Dr. Pickett's qualifications in multi-site operations, corporate strategy, and animal-health technology commercialization were material factors in her selection, making this a material governance event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-22
The filing discloses the appointment of Michael K. Handley as a director of PetVivo Holdings, Inc., effective September 22, 2026, to fill a vacancy created by Joseph Jasper's resignation. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new director with extensive life sciences and capital-raising experience (25+ years, $700M+ raised, $4B+ in transactions). The Board's detailed explanation of Handley's qualifications and the CEO's statement emphasizing his value to the company's growth strategy indicate this is a material governance event affecting board composition and strategic direction.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-09-22
Tonix announced a second major managed Medicare payer agreement for TONMYA® effective immediately, adding approximately 21 million Medicare lives (38% of U.S. Medicare beneficiaries) and bringing total commercial and government coverage to approximately 166 million covered lives (53% of U.S. population). This is a material operational and commercial milestone for the company's flagship product launch, reflecting significant progress in market access and patient reach, but does not fit the specific categories of M&A, debt issuance, earnings release, or other defined event types.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-22
EX-99.1
This press release announces the expansion of TrainAlta's Warrior Training Program across 27 UFC GYM locations in a November 2026 launch cycle, representing approximately 29% growth in location count and described as "the largest launch in the partnership's history." While this is a significant operational and strategic milestone for the company's core business platform, it does not fit neatly into the specific event categories (it is not M&A, a material impairment, a covenant breach, or a discrete financial event like debt issuance). The disclosure is material because it demonstrates material business expansion and growth execution in the company's primary revenue-generating platform, which would affect a reasonable investor's assessment of the registrant's operational trajectory and market penetration strategy.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-09-22
EX-99.1
This press release announces positive metallurgical testwork results from the University of Brighton demonstrating 73% rare earth recovery using in-situ recovery (ISR) methods at IMC's Itarantim Project. The disclosure describes a material operational and strategic development milestone—validation of a potentially lower-cost, lower-capital extraction pathway—that would affect investor assessment of the project's economic viability and development pathway. While not a discrete M&A event, executive change, or financial result, it represents a significant operational advancement for the company's principal project.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-09-22
Idaho Copper disclosed receipt of U.S. Forest Service approval for its Exploration Plan of Operations and 2026 annual operating plan at the CuMo copper-molybdenum project in Idaho. This is a material operational and regulatory milestone that clears the way for drilling and roadbuilding activities to commence after a decade of permitting work. The approval directly enables the company's planned exploration and drilling program, making it a significant operational event that would affect a reasonable investor's assessment of project advancement and execution risk.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-22
The filing discloses Beeline's launch of a "Rate Optimization Program" offering $3,000 lender credits on Bank Statement mortgages, coupled with commentary on Q3 2026 revenue trends and the company's strategic shift toward higher-margin Non-QM mortgage products. While the press release includes forward-looking statements about revenue growth and market opportunity, the core disclosure is a business initiative and product launch rather than a discrete financial event (earnings release, debt issuance, M&A), governance change, or material impairment. This is a material operational/strategic announcement affecting the company's business direction and competitive positioning in the mortgage lending market.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-22
Item 7.01
The disclosure announces favorable regulatory and coding outcomes for Lucid's EsoGuard and EsoCheck products: CMS Medicare Advisory Panel recommended maintaining the original gapfill payment basis, AMA CPT Editorial Panel approved a new Category III CPT code for non-endoscopic cell collection, and CDC/NCHS ICD-10 Coordination Committee favorably received a proposal for a new diagnosis code. These advances directly expand reimbursement and billing pathways for the company's commercial-stage diagnostic products, representing material operational and commercial progress that would affect investor assessment of the company's market access and revenue potential.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
The filing discloses a private placement of 123,650 shares of common stock at $8.50 per share for $1,051,025 in gross proceeds, plus 100% warrant coverage (123,650 warrants at $8.50 exercise price). The securities were offered and sold pursuant to Section 4(a)(2) and Rule 506 exemptions from registration (Item 3.02), and the transaction is structured as an unregistered equity issuance with significant dilution potential. The press release emphasizes this as a premium-priced private placement from returning investors, representing material capital raising activity typical of dilutive issuances at small- and mid-cap companies.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-22
The filing discloses the conditional appointment of two directors, Jeff M. Pies and Dena Lauren Decker, to fill vacancies created by a Board expansion from four to six directors. Although the appointments are conditional on Nasdaq or NYSE listing approval, the Board has taken affirmative action to appoint these individuals effective upon satisfaction of listing conditions. This is a material governance event affecting board composition and is the principal disclosed action under Item 5.02.
View raw filing on EDGAR →
8-K
M&A activity
confidence 92%
filed 2026-09-22
The filing discloses entry into a forward purchase agreement on September 22, 2026, as part of an ongoing business combination between HVII and ONE Nuclear Energy LLC. While the primary business combination agreement was entered into in October 2025, this forward purchase agreement represents a material definitive agreement directly related to the business combination transaction, involving up to 5,000,000 Class A ordinary shares and prepaid cash arrangements. The filing explicitly cites Item 1.01 (Entry into a Material Definitive Agreement) and describes the Forward Purchase Agreement as a financing mechanism supporting the business combination closing.
View raw filing on EDGAR →
8-K
Terminal Other
confidence 95%
filed 2026-09-22
Metal Sky Star Acquisition Corporation announced on September 22, 2026, that it will not seek an extension to complete an initial business combination and will liquidate. The Board approved termination of the SPAC, redemption of public shares at approximately $16.41 per share from the trust account, de-registration with the SEC, de-listing from OTC Markets, and voluntary liquidation. This is a terminal event materially threatening the registrant's continued existence—the company is ceasing all operations except winding up and will cease to exist as a public company.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-09-22
EX-99.1
RedCloud announced a private placement of 74,000 unregistered ordinary shares to CEO Justin Floyd at $2.50 per share ($185,000 aggregate), paid via offset of liabilities owed to Mr. Floyd. This is an unregistered equity issuance that dilutes existing shareholders and represents a material capital transaction, particularly given the substantial premium to market price and the CEO's involvement. The structure (set-off agreement offsetting liabilities) and unregistered nature align with the dilutive_issuance category.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 75%
filed 2026-09-22
Item 5.02
The filing discloses that in connection with Mr. Meadows's appointment as Chief Financial Officer, the Compensation Committee approved a $15,000 monthly consulting fee payable to Myall Luna under an Amendment to a Consulting Services Agreement. While the section mentions Meadows's appointment, the substantive disclosure centers on the Compensation Committee's approval of a compensatory arrangement (the consulting fee), which is the hallmark of exec_compensation. The appointment itself is mentioned only as context ("in connection with"), making the compensation arrangement the principal disclosed action.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-22
The filing discloses that Yakov Baranes was appointed as sole Chief Executive Officer effective September 22, 2026, following the departure of co-CEO Amihay Hadad. While both a departure and appointment occurred, the principal disclosed action centers on the appointment of Baranes to the CEO role, which is a material executive leadership change. The appointment of a sole CEO following a co-CEO structure represents a significant governance transition material to investors.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 95%
filed 2026-09-22
The filing discloses Item 4.01 — a change in the registrant's independent accountant. On September 9, 2026, the Board dismissed UHY LLP as the independent registered public accounting firm and engaged INBERGO CPA LLP as its replacement. The prior auditor's reports contained explanatory paragraphs regarding substantial doubt about the Company's ability to continue as a going concern, and there was a material weakness in internal control over financial reporting. This is material to investors assessing the registrant's financial reporting reliability and going-concern status.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
The filing discloses a registered direct offering of 1,025,640 shares of common stock at $1.17 per share, generating approximately $1.2 million in gross proceeds. Item 1.01 explicitly describes entry into a stock purchase agreement with accredited investors and qualified institutional buyers for this direct equity issuance. This is a classic dilutive equity capital raise that would materially affect shareholder ownership and is disclosed under Item 1.01 as a material definitive agreement.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-22
The filing discloses an amendment to an At Market Issuance Sales Agreement (ATM offering) increasing the maximum aggregate amount of common stock issuable to an additional $6,076,872. This is a dilutive equity issuance under a registered offering, which materially affects shareholder equity and voting power. The company is updating its prospectus supplement to expand the authorized amount of shares available for sale under the existing ATM facility.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-09-22
The primary disclosed event is the termination of a settlement agreement (Item 1.02) that obligated the Company to issue up to 5,000,000 shares to settle outstanding liabilities of approximately $1,418,649. This termination eliminates a material contingent equity obligation and represents a significant financial event. While Item 7.01 discloses an updated investor presentation, the substantive material event is the settlement termination, which is financial in nature but does not fit neatly into specific categories like debt_issuance or dilutive_issuance (those describe creation of obligations, not termination). The termination of a material settlement agreement affecting the Company's capital structure and liability position qualifies as material to a reasonable investor.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-09-22
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-1." This is a distribution to certificate holders of a structured trust, which constitutes a dividend or distribution event. The materiality is high because distributions to security holders are typically material to investors in such instruments, even though the specific distribution amount is not detailed in the excerpt provided.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-09-22
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-2." This is a distribution to certificate holders of a structured trust vehicle. While the disclosure is sparse on details, the core event is a distribution payment, which falls under dividend_distribution. The materiality is marked true because distributions to security holders are typically material to investors in such instruments.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-09-22
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-3." This is a distribution to certificate holders, which constitutes a dividend or distribution event. While the prose is largely boilerplate disclosure about underlying securities and SEC reporting requirements, the core event disclosed is the distribution itself, making this a dividend_distribution classification.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-09-22
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-4." This is a distribution to certificate holders, which falls within the dividend_distribution category. While the disclosure is sparse on details, the core event is a distribution to security holders of a structured product trust.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 75%
filed 2026-09-22
Item 8.01
The filing explicitly states "This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the Select Notes Trust LT 2003-5." This is a distribution to certificate holders, which constitutes a dividend or distribution event. While the prose is largely boilerplate disclosure about underlying security issuers and SEC reporting requirements, the core event disclosed is the distribution itself, making this a dividend_distribution classification.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 75%
filed 2026-09-22
Item 7.01
Silver Bow Mining announced signing of a non-binding term sheet with Ocean Partners for an integrated funding package totaling approximately US$88 million, comprising a US$40 million concentrate prepayment facility, US$43.1 million in reclamation bond guarantees, and a US$5 million equity investment commitment. The prepayment facility is a direct financial obligation bearing interest at 12-month SOFR plus 6.75% per annum with defined repayment terms, and a US$5 million pre-closing bridge note is binding and funded within five business days. While the term sheet itself is non-binding, the bridge note is binding and the overall package represents material new debt financing to fund operations and working capital.
View raw filing on EDGAR →
8-K
M&A activity
confidence 99%
filed 2026-09-22
Item 2.01
Progress Software completed the acquisition of substantially all assets and employees of Domo's AI and data platform business for $400 million in cash on September 22, 2026, pursuant to an Asset Purchase Agreement dated July 22, 2026. The acquisition was funded with cash and existing credit facilities and represents a material strategic addition to Progress' data platform offerings.
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-09-22
EX-99.1
This news release announces exploration results and regulatory approvals at Blue Moon's Springer tungsten project, including assay results from a historical core re-logging campaign (e.g., "7.00 m of 1.28% WO3"), completion of stockpile sampling (499 samples), and BLM approval to drill on public land. These are operational and strategic exploration milestones that advance the project's development and resource understanding, not a discrete financial event, M&A activity, or governance matter. The disclosure is material because it demonstrates progress on a material asset and provides investors with updated technical information about project potential.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 85%
filed 2026-09-22
Item 8.01
News Corporation disclosed daily buy-back notifications to the ASX under its $1 billion repurchase program authorized July 15, 2025. The company repurchased approximately 12.3 million Class A shares and 58,482 Class B shares on September 22, 2026, for approximately $321.7 million in aggregate consideration. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category as a return of capital program, distinct from operational or financial events.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-09-22
Harmony Gold Mining Company Limited announced the pricing of a US$500 million offering of guaranteed senior unsecured convertible bonds due 2031. The announcement discloses the principal terms, coupon rate (1.500% per annum), conversion price (ZAR 418.60), and expected issue date (29 September 2026). This is a material creation of a direct financial obligation and represents a significant capital-raising event for the company.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 92%
filed 2026-09-22
Methanex announced a partial redemption of US$300 million of its outstanding 5.125% senior notes due October 15, 2027, with a redemption date of October 19, 2026. While technically a redemption (retirement) of existing debt rather than issuance of new debt, this represents a material modification of the company's direct financial obligations and capital structure. The CEO's statement emphasizes the company's "strong cash position and cash flow generation capability" and alignment with "balance sheet leverage target," indicating this is a material capital allocation decision affecting the registrant's financial position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-09-22
Item 5.02
Kevin M. Rayment was appointed President and Chief Executive Officer effective January 1, 2027, and elected to the Board of Directors. While the disclosure also includes compensatory arrangements (base salary of $1,100,000, 125% bonus target, and $5,225,000 long-term incentive award), the principal disclosed action is Rayment's appointment to the CEO role and Board membership. This is a material executive succession event affecting the registrant's leadership structure.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-09-22
Item 5.02
Kevin Larkin's separation from his role as Chief Information and Operations Officer, effective September 18, 2026, is a clear executive departure. The filing discloses the notification date and effective date of his departure from a senior officer position, which is material to investors' assessment of the Bank's leadership and operational continuity.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 97%
filed 2026-09-22
Item 2.03
Agree Realty Corporation completed an underwritten public offering of $400 million aggregate principal amount of 5.650% Notes due 2036 on September 22, 2026, generating net proceeds of approximately $390.1 million. The notes are issued by a subsidiary with full guarantee by the parent company and are governed by an indenture with specified restrictive covenants.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-09-22
Item 8.01
TriSalus announced FDA 510(k) clearance for its TriNav Advance device on September 22, 2026, enabling commercialization of a new product in its PEDD portfolio. This is a material regulatory milestone and product launch event that would affect investor assessment of the company's commercial prospects and revenue potential, but it does not fit the specific named categories (earnings, M&A, impairment, litigation, etc.). The event is clearly operational—a regulatory approval and product expansion—making operational_other the most appropriate classification.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-09-22
Item 5.07
Take-Two held its Annual Meeting of stockholders on September 17, 2026, with voting results reported on director elections, executive compensation approval, certificate amendment adoption, and auditor ratification. All ten directors were elected and all four proposals were approved.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-22
Item 8.01
Vistagen announced preliminary positive data from the open-label extension of its PALISADE-4 Phase 3 study of fasedienol for social anxiety disorder, demonstrating safety and efficacy improvements over four months. This is a material clinical milestone for a late-stage biopharmaceutical company's lead product candidate, affecting investor assessment of regulatory pathway and commercialization potential. While not a traditional earnings release or M&A event, the clinical data disclosure represents a significant operational/development milestone that would influence a reasonable investor's view of the company's prospects.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-09-22
Item 3.02
The Fund sold 297,543 Class I common shares for $8.0 million in an unregistered offering exempt under Section 4(a)(2) and Regulation S, materially diluting existing shareholders' ownership percentages.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-09-22
Item 8.01
The Fund declared and disclosed regular monthly distributions to shareholders across multiple share classes (Class I, S, and D) for September through December 2026, with specified per-share amounts and payment dates.
View raw filing on EDGAR →
8-K
M&A activity
confidence 95%
filed 2026-09-22
Item 2.01
The filing discloses completion of a disposition of a multi-building office property in North Carolina for $64 million in cash on September 18, 2026. This is a material asset sale by a real estate company, directly fitting Item 2.01 (Completion of Acquisition or Disposition of Assets). The transaction is material to ACRE's financial position, reducing real estate owned held for sale by $53.9 million and generating approximately $61.9 million in net cash proceeds, as shown in the pro forma balance sheet adjustments.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-09-22
Item 5.07
This Item 5.07 disclosure reports the results of a Special Meeting of Stockholders held on September 21, 2026, where stockholders voted on Proposal 2 (adjournment to solicit additional proxies for a capital authorization increase). The filing tabulates votes for, against, and abstentions (124,584,658 for, 33,639,820 against, 1,989,953 abstentions), which is the core content of shareholder vote results. The material proposal (Proposal 1 to increase authorized common shares by 250 million) was adjourned to October 5, 2026, making this a partial vote result disclosure typical of Item 5.07.
View raw filing on EDGAR →